On Oct. 30, 2024, the American Academy of Dermatology (AAD) announced a new initiative to shed light on hidradenitis suppurativa (HS). In...

A study presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024 in Amsterdam has revealed the potential of...

Recent research has found smoking cessation significantly reduced the risk of developing hidradenitis suppurativa (HS). The findings were...

Researchers have identified genetic risk loci that contribute to the genetic risk of developing hidradenitis suppurativa (HS). The...

Patients with moderate to severe hidradenitis suppurativa (HS) treated with secukinumab demonstrate sustained efficacy and symptom...

New research from France has shown that about two-thirds of patients with chronic inflammatory skin diseases such as adult acne, atopic...

One-third of people with hidradenitis suppurativa (HS) turn to alternative medicine, according to the results of a small study. This...

Patients with moderate-to-severe hidradenitis suppurativa (HS) who are being treated with adalimumab do not need to stop the medication...